AVEO Oncology (United States)

Recent publications and citations

Top Concepts

Top subject area publications in last 5 years

Collaboration Analysis

Publications from 2021 to 2026

Latest Publications

Filter IconFilter

Showing 10 of 127 papers

  • Open Access
  • Research Article

A qualitative interview study exploring the lived experiences of adults, adolescents, and children with chronic inducible cold urticaria

  • Dec 06, 2025
  • Journal of Patient-Reported Outcomes
  • Ashna Alladin +7
  • Research Article

Caplacizumab et immunosuppression sans recours aux échanges plasmatiques dans le Purpura Thrombocytopénique Thrombotique : résultats de l’étude MAYARI

  • Dec 01, 2025
  • La Revue de Médecine Interne
  • Y Benhamou +17
  • Open Access
  • Research Article
  • Citations2

Development of an AAV-delivered microRNA gene therapy for myotonic dystrophy type 1.

  • Dec 01, 2025
  • Molecular therapy : the journal of the American Society of Gene Therapy
  • Giulio S Tomassy +20
  • Open Access
  • Research Article

A Unified Framework for Compressor Stall Inception

  • Nov 07, 2025
  • Journal of Turbomachinery
  • S D Grimshaw +3
  • Open Access
  • Research Article

Reduction in corticosteroid use with rilzabrutinib and sustained response in adults with persistent/chronic immune thrombocytopenia in the long-term extension period of the Phase 3 LUNA3 study

  • Nov 03, 2025
  • Blood
  • David Kuter +11
  • Research Article

Reproductive health in patients with primary immune thrombocytopenia (ITP) receiving rilzabrutinib: A subgroup analysis from the Phase 3 LUNA3 multicenter study

  • Nov 03, 2025
  • Blood
  • Michele P Lambert +10
  • Open Access
  • Research Article

New fitusiran 10 mg dose increases proportion of people with hemophilia within target antithrombin range of 15–35%

  • Nov 03, 2025
  • Blood
  • Guy Young +6
  • Open Access
  • Research Article

Health-related quality of life (HRQoL) in patients with newly diagnosed multiple myeloma (NDMM) eligible for transplantation and treated with isatuximab, lenalidomide, bortezomib, and dexamethasone (Isa-RVd) versus rvd alone: Results from part 1 of the GMMG-HD7 study

  • Nov 03, 2025
  • Blood
  • Elias K Mai +34
  • Research Article
  • Citations1

Isatuximab subcutaneous in relapsed/refractory multiple myeloma: Exposure-response and serum m-protein dynamics analyses from phase 3 iraklia Study and the phase 1b Study

  • Nov 03, 2025
  • Blood
  • Nadia Gaudel +6
  • Research Article

Identification of risk profiles for liver injury in adults with multiple sclerosis using artificial intelligence method.

  • Oct 01, 2025
  • Multiple sclerosis and related disorders
  • Dominique Larrey +12
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.